SOURCE: The Fortune Financial

The Fortune Financial

November 19, 2009 06:53 ET

Global Market Perspective Review on JRCC, HLCS, ISPH, CHIP, GENZ and DSCO From

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by

NEW DELHI, INDIA--(Marketwire - November 19, 2009) - provides the highest level of independent research and investment strategies with the sole purpose of consistently identifying stocks that provide the biggest return on investment for our subscribers. Investors seeking free and unbiased analyst opinions on the companies mentioned in this release are encouraged to register at for a free subscription to access these reports.

Today, we have asked some of the top analysts worldwide to give us their updated feedback regarding the current market activity and position on James River Coal Co. (NASDAQ: JRCC), Helicos BioSciences Corporation (NASDAQ: HLCS), Inspire Pharmaceuticals Inc. (NASDAQ: ISPH), VeriChip Corporation (NASDAQ: CHIP), Genzyme Corp. (NASDAQ: GENZ) and Discovery Laboratories Inc. (NASDAQ: DSCO).

To have free access to these analyst opinions, sign up now to by clicking the link below. We have other reports that could be of interest to you and they are free of charge with no strings attached.

All analyst reviews will be posted for free under "today's articles" within 24 hours they are advertised online.

Each interview will vary and may include, but will not be limited to the following:

--  An Unbiased View of the Company
--  Short-term Target Prices
--  Long-term Resistance and Support Levels
--  Analyst Opinions
--  Sector Review
--  Competition Overview

Investors looking to access these analytical opinions and reports are encouraged to sign up now at

Being a member with gives the unique opportunity to receive a free "custom stock review" on any large cap equity you currently hold in your portfolio. Simply sign up for your free membership today, and in the members section of, you can submit your stock review to an analyst for his or her opinion of any stocks you currently following by filling out the form under the tab "request a stock review." is not affiliated or compensated by any of the above mentioned companies, nor do we own a position in any of the companies.